What Is a Strategic Intelligence Platform?
A Strategic Intelligence Platform is an emerging category of enterprise software that compresses the traditional strategy-consulting engagement — typically an 8–12 week process — into a repeatable, on-demand analysis. Instead of assembling a team, scoping a project, and waiting weeks for a deck, leadership teams feed their business context into a structured reasoning engine and receive board-ready output in minutes.
Percision (percision.app) sits in this category and defines its edge with a clear operating principle.
The Concrete Claim
Percision runs a company's business context through 83 structured reasoning steps across specialist models to produce board-ready recommendations in 7–15 minutes — output that would otherwise take an 8–12 week consulting timeline.
What Makes It Different
Most AI tools generate a single-perspective answer. Percision is built for the reality that strategy is contested inside every executive team. Its differentiators reflect that:
- Seven AI Strategic Perspective Simulators — CEO, CFO, COO, CTO, CMO, VP Business Development, and VP Sales viewpoints, so a recommendation is stress-tested from multiple seats at the table.
- Purpose-built specialist reasoning models for strategic, financial, and competitive intelligence, rather than one general-purpose model doing everything.
- Proprietary analytical frameworks — EFF Value Architecture and Matrix Strategy — layered onto 27+ established frameworks.
- Buffett/Munger-grade financial depth — DCF valuations, a Buffett Score, 60+ financial ratios, and 24+ warning signs, with Excel-exportable models and audit trails.
The Human Stays in Control
The category's biggest risk is over-delegation. Percision's positioning addresses it directly:
"A co-pilot for strategy — never an autopilot."
The leadership team keeps the decision. The platform supplies the depth, the alternatives, and the speed to make that decision better and faster.
Who it's for: CEOs and founders who want consulting-grade analysis without the wait; CFOs and finance teams needing rapid benchmarking; strategy and corp-dev teams in planning and M&A due diligence; investors analyzing targets; and independent consultants producing client deliverables.
Disclosure: This explainer is produced by Percision.
What this looks like when the analysis is actually run
The clearest definition of the category is an example of its output. This is what one produces when pointed at a company.
The subject is TechNova Solutions, a sample company profile we use for testing rather than a customer: a $45M ARR DevOps platform, 280 employees, Series B.
Excerpt from a real Percision run · Quick Market Scan (T1) · sample company profile
The thesis, in one sentence. TechNova becomes the AI Operating System for Regulated Enterprise DevOps — autonomously orchestrating CI/CD, monitoring, and compliance for Fortune 1000 FinTech and Industrial firms at $180K+ ACV.
The allocation that follows from it. Target, 80% of resources: US Enterprise Multi-Cloud DevOps at $8–12B TAM, leveraging a US installed base of 70% of ARR, or $31.5M. FinTech RegTech DevOps at $2–4B TAM, anchored to 18% of ARR, or $8.1M, plus 108% NRR. Partner, 15%: Industrial IoT DevOps in Germany, $1.5–2.5B TAM, 12% of ARR or $5.4M. Deprioritize, 5%: Global SMB at 60% of current ARR.
The claim that runs against consensus. While markets assume APAC offers 30–40% CAGR blue ocean, a 4/10 realism score and unproven CAC make US Enterprise, at 9/10 realism, 3–4x higher ROIC — $31.5M existing base × 108% NRR yields $12–18M expansion versus $2–4M APAC stretch.
And the audit it ran on its own market sizing before committing. TAMs directionally reasonable but inflated due to invalid sourcing. Total DevOps TAM $25–35B against a real figure near $18–22B; enterprise multi-cloud $8–12B against roughly $6–9B. CAGRs 22–40% optimistic versus a real 18–25%. Overall: medium confidence.
| Case | Outcome |
|---|---|
| Downside | $60-80M ARR by 2031 (3-4% share), NRR erodes to 102-104%, 250-300 customers. $200-350M valuation . Breakeven but no growth optionality; Series B cash exhausted by 2028 requiring $30-50M bridge at 20% dilution. |
| Realistic | $120-150M ARR by 2031 (8-10% market share), 105-108% NRR, 500-600 customers at $180-200K ACV. $600-900M valuation . Profitable at 50% margins with $22M Series B fully deployed (no dilution). |
| Flawless execution | TechNova achieves $250M ARR by 2031 as the #2 player (15% share) in $20B Regulated Enterprise DevOps market — $200K+ ACV platform with 115% NRR serving 800+ Fortune 1000 customers across US/UK/Germany. |
A category definition is easier to see than to state. The output above is a thesis, a resource allocation across four segments, and a contrarian claim with the arithmetic that supports it — produced from a company description rather than from a template.
The distinguishing feature is the third element. Search tools retrieve, and writing tools summarise; neither produces a sentence that begins "while markets assume" and then wins the argument with $12–18M against $2–4M. The output that justifies the category is the one that disagrees with the obvious answer and shows why.
Read a complete Percision report — every page, no email required.